<DOC>
	<DOCNO>NCT00236106</DOCNO>
	<brief_summary>Main objective : ass short term growth child atopic dermatitis treatment tacrolimus 0.1 % mometasone furoate 0.1 % . A singl blind randomise cross trial include 20 child . The study consist 5 period : run , treatment ( 1 ) , wash , treatment ( 2 ) run . Each period 14 day child use tacrolimus ointment tvice daily , mometasone furoate daily moisturizer ( run wash run )</brief_summary>
	<brief_title>Short Term Growth Children With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>age 514 , atopic dermatitis , normal current growth , Tanner 1 , inform consent parent guardian , willing able comply study procedure Tanner 25 , treatment atopic dermatitis antiinflammatory agent within 1 week first visit , current asthma rhinoconjunctivitis require treatment glucocorticoid , endocrine disease , major surgery within 4 week prior visit 1 , fever &gt; 39.5 &gt; 3 day</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>March 2005</verification_date>
</DOC>